comprehensive -WSS

comprehensive

author：entertainment 2025-10-02 23:48:16 - browse：3727

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious.

The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant Medtronic, both of which have made surgical systems to treat hypertension.

Data from an analysis of three randomized clinical trials of ReCor Medical’s device showed a modest decrease in blood pressure after two months compared to a control group that received a placebo procedure. Medtronic’s late-stage trial showed that renal denervation reduced hypertension when measuring blood pressure in the doctor’s office, but did not show a reduction in blood pressure when patients measured it at home over 24 hours. At-home blood pressure is considered the more accurate measure, as blood pressure levels tend to artificially rise with anxiety in the clinic. Neither study presented serious safety concerns.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： RSV vaccines may be linked to small increased risk of developing GBS

WSS

Nobel honors Karikó and Weissman's enduring partnership

Setback for rare diseases as Taysha Gene Therapies pulls back

How to fix the rural physician shortage in the U.S.

Health insurers' Q3 question: how much care are people getting?

Nobel honors Karikó and Weissman's enduring partnership

Some top drug companies are starting to take action on climate

knowledge

comprehensive

focus

Virginia high school admissions case could be legal follow

Will an HIV vaccine ever be a reality?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

European officials brace for rough respiratory virus season

Wildfire smoke exposes gaps in outdoor worker protections

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

BioMarin wins approval for gene therapy to treat hemophilia A

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

New air purifier tech could be key to improving indoor air quality

FDA does about

hotspot

Scientists unlock the key to scar

An inside look at PIPEs, biotech's buzzy new financing tool

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Nobel honors Karikó and Weissman's enduring partnership

Study points to new risk in gene therapy death of Terry Horgan

Congress extends some pandemic preparedness programs

explore

entertainment

entertainment

hotspot